PABFX
Price
$18.38
Change
-$0.11 (-0.59%)
Updated
Jul 7 closing price
Net Assets
1.02B
RLBCX
Price
$36.44
Change
-$0.20 (-0.55%)
Updated
Jul 7 closing price
Net Assets
252.39B
Interact to see
Advertisement

PABFX vs RLBCX

Header iconPABFX vs RLBCX Comparison
Open Charts PABFX vs RLBCXBanner chart's image
PGIM Balanced Z
Price$18.38
Change-$0.11 (-0.59%)
VolumeN/A
Net Assets1.02B
American Funds American Balanced R3
Price$36.44
Change-$0.20 (-0.55%)
VolumeN/A
Net Assets252.39B
PABFX vs RLBCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PABFX vs. RLBCX commentary
Jul 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PABFX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 252B vs. PABFX (1.02B). PABFX pays higher dividends than RLBCX: PABFX (2.28) vs RLBCX (1.57). PABFX was incepted earlier than RLBCX: PABFX (33 years) vs RLBCX (23 years). RLBCX (0.89) is less costly to investors than PABFX (0.84). PABFX is a more actively managed with annual turnover of: 107.00 vs. RLBCX (44.00). PABFX has a lower initial minimum investment than RLBCX: PABFX (0) vs RLBCX (250). RLBCX annual gain was more profitable for investors over the last year : 7.52 vs. PABFX (4.73). RLBCX return over 5 years is better than : 39.59 vs. PABFX (29.63).
PABFXRLBCXPABFX / RLBCX
Total Expense Ratio0.780.8988%
Annual Report Gross Expense Ratio0.840.8994%
Fund Existence33 years23 years-
Gain YTD6.7527.91785%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.02B252B0%
Annual Yield % from dividends2.281.57145%
Returns for 1 year4.737.5263%
Returns for 3 years32.3234.0195%
Returns for 5 years29.6339.5975%
Returns for 10 years40.8962.1466%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GDEV15.750.65
+4.30%
GDEV Inc
FN294.665.83
+2.02%
Fabrinet
CGON26.900.22
+0.82%
CG Oncology
PTIX3.46-0.02
-0.57%
Protagenic Therapeutics Inc
NINE0.84-0.02
-2.73%
Nine Energy Service